Today’s Solutions: March 28, 2024

On average, the pharmaceutical industry creates 100kg of waste for every 1kg of small-molecule drug synthesized, which creates a lot of toxic waste. Furthermore, nitrogen-containing chemicals called primary amines, which are used in the majority of all pharmaceuticals, are sought after in the development process. Although these approaches are far from ideal in our current climate, people need these life-saving medications.

A research team from the University of Bath came up with an ingenious idea to cut the waste produced in these processes down dramatically. Dr. Cresswell, the leader of the laboratory stated: “Making pharmaceuticals can be a wasteful process, with most of that waste being incinerated… People don’t really think about the pharmaceutical industry when it comes to carbon emissions, but some studies have calculated that big pharma emits more than the automotive industry.”

So how does it work?

The method uses a blue light-sensitive catalyst as the key player in the process. This molecule is able to capture energy from the light source, then channel it back into the reaction. The outcome? Dramatic acceleration of the drug-making process and the cutting out of many in-between steps. Scientists have been stumped trying to efficiently produce primary amines for decades, making the work published in the Journal of the American Chemical Society (JACS) an urgently needed discovery.

Applying the method to the industry

The method was tested by synthesizing Fingolimod, a widely popular drug for multiple sclerosis (MS), which had worldwide sales in 2020 of €3 billion. The drug was produced successfully using this method, showing the huge potential of this method to revolutionize the industry.

“We’re really excited that our group is the first in the world to achieve this breakthrough, and hope that it could in the future lead to much more sustainable pharmaceutical manufacturing processes,” said Cresswell. In the meantime, whilst we wait for the industry to catch up, the discovery and development of drugs can be made easier and more environmentally friendly using this method.

Source study: Journal of the American Chemical Society (JACS)Photocatalytic Hydroaminoalkylation of Styrenes with Unprotected Primary Alkylamines

Solutions News Source Print this article
More of Today's Solutions

Rowing against the current: Botswana’s women safari guides inspire and empower

In the calm of Botswana's Okavango Delta, where the morning sun creates a golden glow on the water's surface, an amazing metamorphosis is occurring. ...

Read More

The future of healing: 3D printing skin directly onto open wounds

Pennsylvania State University researchers achieved a major medical science breakthrough by being the first team ever to 3D print real human skin tissue directly ...

Read More

These solar-powered barges can scoop up 50 tons of plastic from rivers each day

While removing the plastic waste that currently contaminates the ocean today will be crucial for protecting marine ecosystems, it is arguably more important that ...

Read More

A bold step towards climate action and job creation: The American Climate Corps

The White House announced the creation of the American Climate Corps, a breakthrough program that will transform the climate action landscape. This ambitious project ...

Read More